Advances in CGRP Monoclonal Antibodies as Migraine Therapy: A Narrative Review.
Quick Facts
What This Study Found
CGRP mAbs decrease headache days and improve disability in migraine patients.
Key Numbers
How They Did This
The article is a narrative review summarizing recent advances in CGRP monoclonal antibody therapy for migraines.
Why This Research Matters
CGRP mAbs represent a significant advancement in migraine treatment, addressing the need for more effective and safer options. This could lead to better management of a condition that affects many individuals.
What This Study Doesn't Tell Us
The review does not provide new experimental data and relies on existing studies, which may vary in quality and scope.
Trust & Context
- Original Title:
- Advances in CGRP Monoclonal Antibodies as Migraine Therapy: A Narrative Review.
- Published In:
- Saudi journal of medicine & medical sciences, 11(1), 11-18 (2023)
- Authors:
- Aditya, Suruchi, Rattan, Aditya
- Database ID:
- RPEP-06668
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06668APA
Aditya, Suruchi; Rattan, Aditya. (2023). Advances in CGRP Monoclonal Antibodies as Migraine Therapy: A Narrative Review.. Saudi journal of medicine & medical sciences, 11(1), 11-18. https://doi.org/10.4103/sjmms.sjmms_95_22
MLA
Aditya, Suruchi, et al. "Advances in CGRP Monoclonal Antibodies as Migraine Therapy: A Narrative Review.." Saudi journal of medicine & medical sciences, 2023. https://doi.org/10.4103/sjmms.sjmms_95_22
RethinkPeptides
RethinkPeptides Research Database. "Advances in CGRP Monoclonal Antibodies as Migraine Therapy: ..." RPEP-06668. Retrieved from https://rethinkpeptides.com/research/aditya-2023-advances-in-cgrp-monoclonal
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.